Displaying 1 - 20 of 42
Karen Cornish-Adebiyi, et al. v. Caesars Entertainment, Inc., et al.
Teva Pharmaceuticals USA, Inc. v. Amneal Pharmaceuticals, Inc.
Sollers Education, LLC, FTC v.
Hackensack Meridian Health, Inc. and Englewood Healthcare Foundation
The Federal Trade Commission filed an administrative complaint and authorized a suit in federal court, to block Hackensack Meridian Health, Inc.’s proposed acquisition of Englewood Healthcare Foundation. The complaint alleges that the merged healthcare system would control three of the six inpatient general acute care hospitals in Bergen County, New Jersey. The proposed acquisition would eliminate close competition between Hackensack Meridian Health and Englewood in Bergen County and leave insurers with few alternatives for inpatient general acute care services, which encompass a broad range of inpatient medical and surgical diagnostic and treatment services that require an overnight hospital stay. The administrative trial will begin 30 days after the Third Circuit Court of Appeals rules on the appeal of the Preliminary Injunction.
Environmental Safety International, Inc.
In July 2021, the owners of a New Jersey-based company that sells septic tank cleaning products agreed to a permanent ban on telemarketing and will pay more than $1.6 million to settle FTC charges that the company and its telemarketer made illegal robocalls to consumers, including tens of millions of calls to numbers listed on the agency’s DNC Registry. In addition, the defendants will turn over a residential property as part of the settlement. The complaint names as defendants: Environmental Safety International, Inc. or ESI; ESI’s two officers, brothers Joseph Carney and Sean Carney; and their other brother Raymond Carney.
Gerber Products Co., doing business as Nestlé Nutrition, et al.
In October 2014, the FTC charged Gerber Products Co. with deceptively advertising that feeding its Good Start Gentle formula to infants with a family history of allergies prevents or reduces the risk that they will develop allergies. The FTC also alleged that Gerber falsely advertised Good Start Gentle’s health claims as FDA-approved. The stipulated court order announced today, which the court has entered as final, settles the FTC’s charges and prohibits Gerber from similar conduct in the future.
Takeda Pharmaceutical Company Limited, et al. v. Zydus Pharmaceuticals (USA) Inc., et al.
VIZIO, INC. and VIZIO Inscape Services, LLC
Wyndham Worldwide Corporation
Rise-N-Shine, LLC (Go Away Gray)
Lane Labs-USA, Inc., et al.
Mylan Pharmaceuticals, Inc. v. Celgene Corporation
In re Effexor XR Antitrust Litigation
Actelion Pharmaceuticals Ltd., et al. v. Apotex Inc.
Circa Direct LLC, and Andrew Davidson,FTC
In re Lamictal Direct Purchaser Antitrust Litigation
In re Effexor XR Antitrust Litigation
Millennium Telecard, Inc., et al.
Displaying 1 - 20 of 42